Fn participates in development of various malignant tumors, such as those related to colorectal, gastric, pancreatic, breast, and head and neck cancer, and promotes mechanisms related to their progression, including immune evasion, epithelial-mesenchymal transformation, and chemotherapy resistance [20,21]. This evidence concerns the gene FN1 and head and neck cancer.